Home > Insider Trading > Filing (0001209191-19-002796)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236934	J Paula Swain	1801 Augustine Cut-Off Wilmington DE 19803	Evp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-01-04	30,000	$18.32	62,324	No	4	M	Direct
Common Stock	Disposition	2019-01-04	30,000	$70.00	32,324	No	4	S	Direct
Common Stock	Disposition	2019-01-07	1,200	$74.21	31,124	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2019-01-04	22,772	$0.00	22,772	$72.27
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2019-01-04	31,552	$0.00	31,552	$72.27
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2019-01-04	30,000	$0.00	30,000	$18.32

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,772	2029-01-03	No	4	A	Direct
31,552	2029-01-03	No	4	A	Direct
21,782	2020-02-08	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
This includes an aggregate of 5,416 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.
Beginning January 4, 2019, options become exercisable in full on January 4, 2023.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.